Ignite Creation Date:
2025-12-25 @ 12:34 AM
Ignite Modification Date:
2026-02-20 @ 6:05 PM
Study NCT ID:
NCT02158767
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2025-03-12
First Post:
2014-06-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.
Sponsor:
Leland Metheny
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE16Z13
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None